Patents by Inventor Thomas R. Reynolds

Thomas R. Reynolds has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11913006
    Abstract: The present invention relates to methods of producing industrial products from plant lipids, particularly from vegetative parts of plants. In particular, the present invention provides oil products such as biofuel, and processes for producing these products, as well as plants having an increased level medium chain fatty acids such as lauric acid and myristic acid. In one particular embodiment, the present invention relates to combinations of modifications in a fatty acid thioesterase and one or more acyltransferases. In an embodiment, the present invention relates to a process for extracting lipids. In another embodiment, the lipid is converted to one or more hydrocarbon products in harvested plant vegetative parts to produce alkyl esters of the fatty acids which are suitable for use as a renewable biofuel.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: February 27, 2024
    Assignee: NUSEED GLOBAL INNOVATION LTD.
    Inventors: Kyle B. Reynolds, Thomas Vanhercke, Anna El Tahchy, Qing Liu, Surinder S. Singh, James R. Petrie
  • Patent number: 7338761
    Abstract: In clinical settings as well as in a drug development context, human herpes viruses can be detected, and even quantified, by the use of a real time PCR-based assay. An informatics analysis of existing gene sequences from different HHV types or strains is used to identify a target segment within a gene. A probe oligonucleotide and at least two primer oligonucleotides are then designed for selectively directing the amplification, in the course of a single amplification reaction, of the target segment of a particular HHV type or strain. This method is capable of an unprecedented level of discrimination among the following HHV types and strains: HHV1, drug resistant HHV1, HHV2, drug resistant HHV2, HHV3, HHV4a, HHV4b, HHV5, HHV6a, HHV6b, HHV7, and HHV8.
    Type: Grant
    Filed: October 12, 2001
    Date of Patent: March 4, 2008
    Assignee: Vigen Laboratories Inc.
    Inventors: Thomas R. Reynolds, Robert B. Harris
  • Publication number: 20040072147
    Abstract: In clinical settings as well as in a drug development context, human herpes viruses can be detected, and even quantified, by the use of a real time PCR-based assay. An informatics analysis of existing gene sequences from different HHV types or strains is used to identify a target segment within a gene. A probe oligonucleotide and at least two primer oligonucleotides are then designed for selectively directing the amplification, in the course of a single amplification reaction, of the target segment of a particular HHV type or strain. This method is capable of an unprecedented level of discrimination among the following HHV types and strains: HHV1, drug resistant HHV1, HHV2, drug resistant HHV2, HHV3, HHV4a, HHV4b, HHV5, HHV6a, HHV6b, HHV7, and HHV8.
    Type: Application
    Filed: September 8, 2003
    Publication date: April 15, 2004
    Inventors: Thomas R. Reynolds, Robert B. Harris
  • Patent number: 6664065
    Abstract: In clinical settings as well as in a drug-discovery context, the impact of an agent that may affect reverse transcriptase (RT) can be measured and even quantified by bringing a sample, which may contain an RT, into contact with an RNA template, a primer complementary to the RNA template, and appropriate oligonucleotide-specific primers, under conditions such that they react, in the presence of RT, to form a cDNA product in inverse proportion to the effect of the agent. The amount of any resultant cDNA product then can be measured. The approach is readily implemented as a real-time, quantitative kinetic assay for RT activity.
    Type: Grant
    Filed: April 24, 2002
    Date of Patent: December 16, 2003
    Inventors: Robert B. Harris, Thomas R. Reynolds
  • Publication number: 20020192641
    Abstract: In clinical settings as well as in a drug-discovery context, the impact of an agent that may affect reverse transcriptase (RT) can be measured and even quantified by bringing a sample, which may contain an RT, into contact with an RNA template, a primer complementary to the RNA template, and appropriate oligonucleotide-specific primers, under conditions such that they react, in the presence of RT, to form a cDNA product in inverse proportion to the effect of the agent. The amount of any resultant cDNA product then can be measured. The approach is readily implemented as a real-time, quantitative kinetic assay for RT activity.
    Type: Application
    Filed: April 24, 2002
    Publication date: December 19, 2002
    Inventors: Robert B Harris, Thomas R Reynolds
  • Patent number: 6110683
    Abstract: The present invention provides a reagent which can be used as a marker to identify individual lanes on an electrophoresis gel which is run on an Automated DNA Sequencer. This reagent is may be included in the loading dye for samples in DNA sequencing, DNA fragment analysis, or linkage mapping analysis. Inclusion of the reagent aids in the identification of the lane in which each sample is individually loaded on the acrylamide gel, such that the data read from each lane by the instrument is correctly applied to the appropriate sample.
    Type: Grant
    Filed: January 29, 1999
    Date of Patent: August 29, 2000
    Assignee: Commonwealth Biotechnologies, Inc.
    Inventors: Thomas R. Reynolds, Gregory A. Meyers, Gregory A. Buck, Joshua Rameaka